139 related articles for article (PubMed ID: 21470651)
1. Resting lymphocyte transduction with measles virus glycoprotein pseudotyped lentiviral vectors relies on CD46 and SLAM.
Zhou Q; Schneider IC; Gallet M; Kneissl S; Buchholz CJ
Virology; 2011 May; 413(2):149-52. PubMed ID: 21470651
[TBL] [Abstract][Full Text] [Related]
2. Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors.
Frecha C; Lévy C; Costa C; Nègre D; Amirache F; Buckland R; Russell SJ; Cosset FL; Verhoeyen E
J Virol; 2011 Jun; 85(12):5975-85. PubMed ID: 21450813
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
[TBL] [Abstract][Full Text] [Related]
4. Reduced ability of hemagglutinin of the CAM-70 measles virus vaccine strain to use receptors CD46 and SLAM.
Kato S; Ohgimoto S; Sharma LB; Kurazono S; Ayata M; Komase K; Takeda M; Takeuchi K; Ihara T; Ogura H
Vaccine; 2009 Jun; 27(29):3838-48. PubMed ID: 19490984
[TBL] [Abstract][Full Text] [Related]
5. V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor.
Ono N; Tatsuo H; Tanaka K; Minagawa H; Yanagi Y
J Virol; 2001 Feb; 75(4):1594-600. PubMed ID: 11160657
[TBL] [Abstract][Full Text] [Related]
6. Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion.
Tahara M; Takeda M; Yanagi Y
J Virol; 2007 Jul; 81(13):6827-36. PubMed ID: 17442724
[TBL] [Abstract][Full Text] [Related]
7. Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently.
Tahara M; Takeda M; Seki F; Hashiguchi T; Yanagi Y
J Virol; 2007 Mar; 81(6):2564-72. PubMed ID: 17182683
[TBL] [Abstract][Full Text] [Related]
8. Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model.
Vongpunsawad S; Oezgun N; Braun W; Cattaneo R
J Virol; 2004 Jan; 78(1):302-13. PubMed ID: 14671112
[TBL] [Abstract][Full Text] [Related]
9. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
Sugiyama T; Yoneda M; Kuraishi T; Hattori S; Inoue Y; Sato H; Kai C
Gene Ther; 2013 Mar; 20(3):338-47. PubMed ID: 22717740
[TBL] [Abstract][Full Text] [Related]
10. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor.
Ono N; Tatsuo H; Hidaka Y; Aoki T; Minagawa H; Yanagi Y
J Virol; 2001 May; 75(9):4399-401. PubMed ID: 11287589
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas.
Paraskevakou G; Allen C; Nakamura T; Zollman P; James CD; Peng KW; Schroeder M; Russell SJ; Galanis E
Mol Ther; 2007 Apr; 15(4):677-86. PubMed ID: 17299404
[TBL] [Abstract][Full Text] [Related]
12. Analysis of receptor (CD46, CD150) usage by measles virus.
Erlenhöfer C; Duprex WP; Rima BK; Ter Meulen V; Schneider-Schaulies J
J Gen Virol; 2002 Jun; 83(Pt 6):1431-1436. PubMed ID: 12029158
[TBL] [Abstract][Full Text] [Related]
13. SLAM (CDw150) is a cellular receptor for measles virus.
Tatsuo H; Ono N; Tanaka K; Yanagi Y
Nature; 2000 Aug; 406(6798):893-7. PubMed ID: 10972291
[TBL] [Abstract][Full Text] [Related]
14. A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism.
Takeda M; Tahara M; Hashiguchi T; Sato TA; Jinnouchi F; Ueki S; Ohno S; Yanagi Y
J Virol; 2007 Nov; 81(21):12091-6. PubMed ID: 17715217
[TBL] [Abstract][Full Text] [Related]
15. Differential receptor usage by measles virus strains.
Bartz R; Firsching R; Rima B; ter Meulen V; Schneider-Schaulies J
J Gen Virol; 1998 May; 79 ( Pt 5)():1015-25. PubMed ID: 9603316
[TBL] [Abstract][Full Text] [Related]
16. Faster replication and higher expression levels of viral glycoproteins give the vesicular stomatitis virus/measles virus hybrid VSV-FH a growth advantage over measles virus.
Ayala-Breton C; Russell LO; Russell SJ; Peng KW
J Virol; 2014 Aug; 88(15):8332-9. PubMed ID: 24829351
[TBL] [Abstract][Full Text] [Related]
17. Interactions among measles virus hemagglutinin, fusion protein and cell receptor signaling lymphocyte activation molecule (SLAM) indicating a new fusion-trimer model.
Zhang P; Li L; Hu C; Xu Q; Liu X; Qi Y
J Biochem Mol Biol; 2005 Jul; 38(4):373-80. PubMed ID: 16053702
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of measles virus entry and dissemination through different receptors.
Schneider U; von Messling V; Devaux P; Cattaneo R
J Virol; 2002 Aug; 76(15):7460-7. PubMed ID: 12097558
[TBL] [Abstract][Full Text] [Related]
19. Heparin-like glycosaminoglycans prevent the infection of measles virus in SLAM-negative cell lines.
Terao-Muto Y; Yoneda M; Seki T; Watanabe A; Tsukiyama-Kohara K; Fujita K; Kai C
Antiviral Res; 2008 Dec; 80(3):370-6. PubMed ID: 18812191
[TBL] [Abstract][Full Text] [Related]
20. SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein.
Hashimoto K; Ono N; Tatsuo H; Minagawa H; Takeda M; Takeuchi K; Yanagi Y
J Virol; 2002 Jul; 76(13):6743-9. PubMed ID: 12050387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
